Clinical Trial for Breast Cancer and Head and Neck Cancer.

The purpose of this clinical trial is to provide study medicine(s) and learn about their safety. This study is seeking participants who:

Have benefited from ongoing study treatment as determined by the study doctor in a Pfizer-sponsored palbociclib Parent Study
Must agree to follow the reproductive criteria
Are willing and able to comply with all scheduled visits, treatment plans, and other study procedures
Can give signed informed consent documents

Participants in this study will continue to receive treatment as they were in the parent study. The time by which participants will take part in this study is retrospective (after completed parent study). We will examine the experiences of people receiving the study medicine(s). This will help us determine if the study medicine(s) are safe. During this time, the participants will be monitored for the safety of the study medicine(s).

Closest Location

To find study locations, use the location search box below.

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Breast Cancer, Head and Neck Cancer

Sex

Male or Female

Age

18+ years

View more eligibility criteria on ClinicalTrials.gov

`

Join PfizerConnect

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

Who may participate

View locations for this study

Nearest Locations found

Join PfizerConnect

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

Who may participate

View locations for this study

Nearest Locations found

Are you a Healthcare Professional?